Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: An ex vivo and in vitro study

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Van Weyenbergh, Johan ^a,b   Santana, Gisélia ^a   D'Oliveira Jr , Argemiro ^c   Santos Jr , Anibal F ^d   Costa, Carlos H ^e   Carvalho, Edgar M ^b,c   Barral, Aldina ^a,b   Barral Netto, Manoel ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Institute for Investigation in Immunology INCT   (Brazil)

^c HUPES   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 5; MEGLUMINE ANTIMONATE; TRACE METAL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ZINC; PROTOZOON ANTIBODY;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BACTERIAL IMMUNITY; BLOOD SAMPLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EX VIVO STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IN VITRO STUDY; INFECTION SENSITIVITY; INHIBITION KINETICS; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; LYMPHOCYTE PROLIFERATION; MALE; QUANTITATIVE ANALYSIS; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS; ZINC DEFICIENCY; ADOLESCENT; ANIMAL; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; COPPER; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; MALE; TH1 CELLS; TH2 CELLS; ZINC;

EID: 10444281517     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-4-50     Document Type: Article

References (21)

1. Desjeux P: The increase in risk factors for leishmaniasis worldwide. Trans Roy Soc Trop Med Hyg 2001, 95:239-43.
2. Coffman RL, Chatelain R, Leal LM, Varkila K: Leishmania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation. Res Immunol 1991, 142:36-40.
3. Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995, 13:151-77.
4. Rocha PN, Almeida RP, Bacellar O, de Jesus AR, Filho DC, Filho AC, Barral A, Coffman RL, Carvalho EM: Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis 1999, 180:1731-4.
5. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM: Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998, 31:143-8.
6. Carvalho EM, Badaro R, Reed SG, Jones TC, Johson WD Jr: Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 1985, 76:2066-9.
7. Badaro R, Falcoff E, Badaro FS, Carvalho EM, Pedral-Sampaio D, Barral A, Carvalho JS, Barral-Netto M, Brandely M, Silva L: Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 1990; 322:16-21.
8. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997, 272:E1002-7.
9. Kocyigit A, Erel O, Gurel MS, Avci S, Akteje N. Alterations of serum selenium, zinc, copper, and iron concentrations and some related antioxidant enzyme activities in patients with cutaneous leishmaniasis. Biol Trace Elem Res 1998;65:271-81.
10. Dominguez M, Torano A: Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection. J Exp Med 1999, 189:25-35.
11. Bogden JD, Kemp FW, Han S, Li W, Bruening K, Denny T, Oleske JM, Lloyd J, Baker H, Perez G, Kloser P, Skurnick J, Louria DB: Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr 2000, 72:809-15.
12. Aston NS, Watt N, Morton IE, Tanner MS, Evans GS. Copper toxicity affects proliferation and viability of human hepatoma cells (HepG2 line). Hum Exp Toxicol 2000, 19:367-76.
13. Van Weyenbergh J:. Identification of molecular targets for zinc regulation of human monocyte metabolism. PhD Thesis. Catholic University Leuven, Faculty of Sciences; 1995.
14. Santos MA, Marques RC, Farias CA, Vasconcelos DM, Stewart JM, Costa DL, Costa CH: Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis. Rev Soc Bras Med Trop 2002, 35:629-33.
15. Werneck GL, Batista MS, Gomes JR, Costa DL, Costa CH: Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil. Infection 2003, 31:174-7.
16. Theocharis S. Margeli A, Panayiotidis P: Effects of various metals on DNA synthesis and lymphokines production by human peripheral blood lymphocytes in vitro. Comp Biochem Physiol C 1991, 99:131-3.
17. Araya M, Koletzko B, Uauy R: Copper deficiency and excess in infancy: developing a research agenda. J Pediatr Gastroenterol Nutr 2003, 37:422-9.
18. Sharifi I, FeKri AR, Aflatonian MR, Aflatonian MR, Khamesipour A, Nadim A: Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998, 351:1540-3.
19. Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib H W, Musa B: Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet 2000, 356:1565-9.
20. Brewer GJ: Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med 2000, 223:39-46.
21. Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ: Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001, 26:21-6.